Population
39-year-old pregnant woman with a history of mitral valve replacement 23 years prior (n=1)
Design
Case_report
Follow-up
Up to 23 weeks of gestation
Authors
Loading...
Maternal PT/INR may not ensure fetal safety with warfarin; this case leaves open optimal monitoring and alternative strategies.
This case highlights that maternal PT/INR does not correlate well with fetal warfarin activity, and fetal intracranial hemorrhage can occur despite strict maternal coagulation control.
Masamoto et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: